BRL-44408
![]()  | |
| Identifiers | |
|---|---|
  | |
| CAS Number | 
118343-19-4  | 
| PubChem (CID) | 121850 | 
| IUPHAR/BPS | 525 | 
| ChemSpider | 
108707  | 
| ChEMBL | 
CHEMBL216097  | 
| Chemical and physical data | |
| Formula | C13H17N3 | 
| Molar mass | 215.293 g/mol | 
| 3D model (Jmol) | Interactive image | 
  | |
  | |
|   | |
BRL-44408 is a drug used in scientific research which acts as a selective antagonist for the α2A adrenoreceptor.[1] It has been suggested as having potential therapeutic application in the treatment of extrapyramidal side effects produced by some antipsychotic medications.[2]
References
- ↑ Alberts P (January 1993). "Subtype classification of presynaptic alpha 2-adrenoceptors". General Pharmacology. 24 (1): 1–8. PMID 8387042.
 - ↑ Imaki J, Mae Y, Shimizu S, Ohno Y (April 2009). "Therapeutic potential of alpha2 adrenoceptor antagonism for antipsychotic-induced extrapyramidal motor disorders". Neuroscience Letters. 454 (2): 143–7. doi:10.1016/j.neulet.2009.03.001. PMID 19429072.
 
This article is issued from Wikipedia - version of the 5/21/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
